Jpmorgan Chase & CO Biomerica Inc Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Dec 26, 2024	BUY	$0.82 - $1.29 $31 - $50	39 New	39 $0
Q1 2024 May 10, 2024	BUY	$0.82 - $1.29 $9 - $14	11 Added 39.29%	39 $0
Q4 2023 Dec 26, 2024	BUY	$0.71 - $1.65 $19 - $46	28 New	28 $0
Q4 2023 Feb 12, 2024	BUY	$0.71 - $1.65 $6 - $14	9 Added 47.37%	28 $0
Q3 2023 Nov 14, 2023	BUY	$0.82 - $1.65 $15 - $31	19 New	19 $0
Q1 2023 May 11, 2023	BUY	$1.86 - $3.56 $3,720 - $7,120	2,000 New	2,000 $3,000

1.79M

53.7K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $4.3M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.